Cargando…
Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing
Epidemiological studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce colorectal cancer incidence. We measured the rate ratio for colorectal adenocarcinoma according to dosage and the timing of exposure by means of a case–control study, nested in a non-concurrent cohort linkage stu...
Autores principales: | Collet, J-P, Sharpe, C, Belzile, E, Boivin, J-F, Hanley, J, Abenhaim, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374346/ https://www.ncbi.nlm.nih.gov/pubmed/10487613 http://dx.doi.org/10.1038/sj.bjc.6690651 |
Ejemplares similares
-
Nested case–control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage
por: Sharpe, C R, et al.
Publicado: (2000) -
Non-steroidal anti-inflammatory drugs and bladder cancer prevention
por: Castelao, J E, et al.
Publicado: (2000) -
The effects of tricyclic antidepressants on breast cancer risk
por: Sharpe, C R, et al.
Publicado: (2002) -
Detection and quantitation of non-steroidal anti-inflammatory drug use close to the time of birth using umbilical cord tissue
por: Price, Hayley R., et al.
Publicado: (2020) -
Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention
por: Maniewska, Jadwiga, et al.
Publicado: (2021)